14 drug(s) with this reaction
40,439 total reports
Back Pain has been reported as an adverse reaction across 14 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 40,439 adverse event reports mention back pain in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with back pain, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have back pain listed in their FDA adverse event reports, sorted by report count:
In addition to back pain, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
14 drug(s) manufactured by Abbvie Inc have back pain listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, UPADACITINIB, FENOFIBRATE, and others.
There are a combined 40,439 reports of back pain across 14 Abbvie Inc drug(s) in the FDA adverse event database.